• Skip to Content
  • Skip to Main Navigation
  • Skip to Information Links
  • Skip to Site Search
  • Skip to Footer
  • Skip to Accessibility Information
  • Home Page

This site is intended for healthcare professionals

Information Links

  • Sign in
  • Register
  • Subscribe
  • About us
  • FAQs
  • Medeconomics
  • GPonline
  • MIMS Learning

Mims Home button

Menu

Main Navigation

  • News
  • Tables
  • Guidelines
  • Visual Guides
  • Clinics
  • Events
Click to search or browse MIMS
  • Drugs
  • Conditions
  • News and resources
  • MIMS Hosted
Browse 3000+ drugs by disease Browse drugs by 500+ manufacturers

Browse news and resources by disease area

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse all
Search Help

  • Trending trending icon
  • COVID vaccines
  • SGLT2 comparison table
  • Shortages tracker
  • HRT comparison

Guidelines - Skin

Quick-reference summaries of key national treatment guidance for dermatological conditions including eczema and psoriasis.

NICE technology appraisals

Decisions by the National Institute for Health and Care Excellence on NHS access to treatments for dermatological conditions. 

  • Ixekizumab for Treating Moderate to Severe Plaque Psoriasis (TA442)

  • Apremilast for Treating Moderate to Severe Plaque Psoriasis (TA419)

  • Nivolumab in Combination with Ipilimumab for Treating Advanced Melanoma (TA400)

  • Trametinib in Combination with Dabrafenib for Treating Unresectable or Metastatic Melanoma (TA396)

  • Adalimumab for Treating Moderate to Severe Hidradenitis Suppurativa (TA392)

  • Secukinumab for Treating Moderate to Severe Plaque Psoriasis (TA350)

  • Ustekinumab for the Treatment of Adults with Moderate to Severe Psoriasis (TA180)

  • Alitretinoin for the Treatment of Severe Chronic Hand Eczema (TA177)

  • Psoriasis, Treatment of Adults: Adalimumab (NICE)

  • Psoriasis in Adults: Infliximab (NICE)

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

  • Cancer
  • Cardiology
  • Child health
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Infectious diseases
  • Men's health
  • Mental health
  • Neurology
  • Ophthalmology
  • Pain
  • Respiratory
  • Rheumatology
  • Smoking cessation
  • Women's health

  • Advertising and Sponsorship
  • Privacy Notice
  • Careers at Haymarket
  • Help
  • Terms and Conditions
  • Contact us
  • Editorial Complaint
  • Sign in
  • Register
  • About us
  • FAQs
  • Medeconomics
  • GPonline
  • MIMS Learning
Haymarket © Haymarket Media Group Ltd. | Terms & Conditions | Cookie Notice | Privacy Notice
IPSO